Diurnal (LON:DNL)

Diurnal (LON:DNL)


Share Price
27.10 p
Change
-3.9 (-12.58 %)
Market Cap
£16.72 m
Proactive Investors - Run By Investors For Investors

Diurnal

Diurnal Group plc is a United Kingdom-based specialty pharmaceutical company. The Company targets patient needs in chronic endocrine (hormonal) diseases, such as congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism and hypothyroidism. The Company has two products in late-stage clinical development targeting adrenal disease: Chronocort and Infacort. The Chronocort is to be...

EPIC: DNL
Market: AIM:DNL
52-week High/Low: 202.00p / 21.00p
Sector: Pharmaceuticals
Market Cap: £16.72 m
Website:
col 3
col 4
col 5
col 6

Diurnal Timeline

RNS
February 11 2019
RNS
January 17 2019
RNS
December 12 2018
RNS
December 04 2018
RNS
November 14 2018

Columns Including DNL

VIEW ALL

Market Reports Including DNL

VIEW ALL

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use